Results 81 to 90 of about 174,213 (263)
Successful use of ketamine in reversing the paradoxical reactions to midazolam after failing flumazenil [PDF]
Midazolam is generally effective and safe to be widely used in the management of seizures, procedural sedation, and anxiolytic. However, paradoxical reactions, though rare, present clinical challenges. Flumazenil is the preferred option for reversing the
Abdullah Nasser Aldosari, Sinan Alnashi
doaj +1 more source
Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions
Members of the solute carrier (SLC) family of transporters are responsible for the cellular influx of a broad range of endogenous compounds and xenobiotics.
Jason T. Anderson +4 more
semanticscholar +1 more source
Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui +10 more
wiley +1 more source
Description of adverse reactions reported in the pharmacovigilance database of province of Las Tunas
Background: adverse drug effects are a health problem on a worldwide scale and increase the costs of hospital care considerably.Objective: to describe the adverse drug reactions reported to the pharmacovigilance database of the province of Las Tunas ...
Sahily Rojas-Pérez +4 more
doaj
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Adverse drug reactions (ADRs) stemming from drug–drug interactions pose a substantial global public health issue, negatively affecting mortality rates, patient morbidity, and the overall burden on healthcare systems.
G. Naidu
semanticscholar +1 more source
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database [PDF]
Background/Aims Few real-world studies explored factors associated with latent tuberculosis infection (LTBI) treatment-related adverse drug reactions (ADRs).
Yu-Seon Jung +4 more
doaj +1 more source
Molecular docking to investigate HLA-associated idiosyncratic drug reactions
Idiosyncratic drug reactions (IDRs) pose severe threats to patient health. Unlike conventionally dose-dependent side effects, they are unpredictable and more frequently manifest as life-threatening conditions, such as severe cutaneous adverse reactions ...
Ke-Jun Li, V. Lauschke, Yi-Tian Zhou
semanticscholar +1 more source

